Overview

Update
Total Equity Funding
$41M in 4 Rounds from 11 Investors
Most Recent Funding
$13.5M Series B on May 12, 2015
Headquarters:
Cleveland, Ohio
Description:
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Founders:
,
Categories:
Therapeutics, Medical Device, Biotechnology, Medical, Life Science
Website:
http://www.juventasinc.com
Social:

Company Details

Update

Juventas Therapeutics is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.

Funding Rounds (4) - $41M

Update
DateAmount / RoundValuationLead InvestorInvestors
May, 2015$13.5M / Series B2
Nov, 2013$5M / Venture0
Jul, 2012$22.2M / Series B8
Sep, 2008$300k / Seed1

Current Team (4)

Update

Offices/Locations (1)

Update
  • HQ

    3615 Superior Avenue,

    Suite 4403C

    Cleveland, Ohio 44114

    United States

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Images

Add Videos